Endoscopic endonasal approach for suprasellar meningiomas: introduction of a new scoring system to predict extent of resection and assist in case selection with long-term outcome data.

endoscopic endonasal approach meningioma planum sphenoidale skull base suprasellar transsphenoidal tuberculum

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
24 Jul 2020
Historique:
received: 14 02 2020
accepted: 27 04 2020
medline: 25 7 2020
pubmed: 25 7 2020
entrez: 25 7 2020
Statut: epublish

Résumé

The endoscopic endonasal approach (EEA) has gained increasing popularity for the resection of suprasellar meningiomas (SSMs). Appropriate case selection is critical in optimizing patient outcome. Long-term outcome data are lacking. The authors systematically identified preoperative factors associated with extent of resection (EOR) and determined the relationship between EOR and long-term recurrence after EEA for SSMs. In this retrospective cohort study, the authors identified preoperative clinical and imaging characteristics associated with EOR and built on the recently published University of California, San Francisco resectability score to propose a score more specific to the EEA. They then examined the relationship between gross-total resection (GTR; 100%), near-total resection (NTR; 95%-99%), and subtotal resection (STR; < 95%) and recurrence or progression with Kaplan-Meier survival analysis. A total of 51 patients were identified. Radiographic GTR was achieved in 40 of 47 (85%) patients in whom it was the surgical goal. Significant independent risk factors for incomplete resection were prior surgery (OR 25.94, 95% CI < 2.00 to 336.49, p = 0.013); tumor lateral to the optic nerve (OR 13.41, 95% CI 1.82-98.99, p = 0.011); and complete internal carotid artery (ICA) encasement (OR 15.12, 95% CI 1.17-194.08, p = 0.037). Tumor size and optic canal invasion were not significant risk factors after adjustment for other variables. A resectability score based on the multivariable model successfully predicted the likelihood of GTR; a score of 0 had a positive predictive value of 97% for GTR, whereas a score of 2 had a negative predictive value of 87.5% for incomplete resection. After a mean follow-up of 40.6 ± 32.4 months (mean ± SD), recurrence was 2.7% after GTR (1 patient with atypical histology), 44.4% after NTR, and 80% after STR (p < 0.0001). Vision was stable or improved in 93.5% and improved in 67.4% of patients with a preoperative deficit. There were 5 (9.8%) postoperative CSF leaks, of which 4 were managed with lumbar drains and 1 required a reoperation. The EEA is a safe and effective approach to SSMs, with favorable visual outcomes in well-selected cases. The combination of postoperative MRI-based EOR with direct endoscopic inspection can be used in lieu of Simpson grade to predict recurrence. GTR dramatically reduces recurrence and can be achieved regardless of tumor size, proximity or encasement of the anterior cerebral artery, or medial optic canal invasion. Risk factors for incomplete resection include prior surgery, tumor lateral to the optic nerve, and complete ICA encasement.

Identifiants

pubmed: 32707549
doi: 10.3171/2020.4.JNS20475
pii: 2020.4.JNS20475
pmc: PMC8111689
mid: NIHMS1697775
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113-125

Subventions

Organisme : NCI NIH HHS
ID : R38 CA231577
Pays : United States

Auteurs

Brett E Youngerman (BE)

Departments of1Neurosurgery and.
2Department of Neurosurgery, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, New York; and.

Matei A Banu (MA)

2Department of Neurosurgery, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York, New York; and.

Mina M Gerges (MM)

Departments of1Neurosurgery and.
3Department of Neurosurgery, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Eseosa Odigie (E)

Departments of1Neurosurgery and.

Abtin Tabaee (A)

4Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital.

Ashutosh Kacker (A)

4Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital.

Vijay K Anand (VK)

4Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital.

Theodore H Schwartz (TH)

Departments of1Neurosurgery and.
4Otolaryngology, Weill Cornell Medicine, NewYork-Presbyterian Hospital.

Classifications MeSH